News Focus
News Focus
Replies to #99877 on Biotech Values
icon url

rwdm

07/27/10 4:34 PM

#99895 RE: DewDiligence #99877

Can you imagine that FDA's demand for a complicated molecule such as Copaxone would be less (without bioequivalence) than for a simple compound such as aspirin?
Thanks for your welcoming.